4D Molecular Therapeutics Inc (FDMT)

Over the past 90 days, 4D Molecular Therapeutics Inc. saw 15 insider transactions, all of which were sales. Executives, including David Kirn and Scott Bizily, offloaded shares totaling approximately $5.63 million. These transactions occurred following the company's May 2026 earnings report, which showed an EPS miss, amid a 3.2% decline in the stock price.
Ticker: FDMT Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for 4D Molecular Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Proposed sale 4 Aug 2026
Value US$4,044,139.80 | Price 419.07 | Shares 9,866
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
9,866
419.07
US$4,044,140
9,866 419.07 US$4,044,140
2026-08-04 2026-08-03 PlS Planned sale

See Remarks

Executive Director
77,320 +14.7%
468.34
US$2,914,244
77,320 +14.7% 468.34 US$2,914,244
2026-08-03 2026-08-03 PrS Proposed sale

Officer

Officer
7,228
22.46
US$666,669
7,228 22.46 US$666,669
2026-07-14 2026-07-10 PlS Planned sale

See Remarks

Executive Director
442 -0.0%
12.84
US$5,673
442 -0.0% 12.84 US$5,673
2026-07-14 2026-07-10 PlS Planned sale

See Remarks

Executive Director
15,283 -1.7%
12.01
US$183,560
15,283 -1.7% 12.01 US$183,560
2026-07-10 2026-07-10 PrS Proposed sale

Officer

Officer
15,725
12.31
US$193,575
15,725 12.31 US$193,575
2026-07-14 2026-07-09 PlS Planned sale

See Remarks

Executive Director
42,608 -4.5%
12.87
US$548,177
42,608 -4.5% 12.87 US$548,177
2026-07-09 2026-07-09 PrS Proposed sale

Officer

Officer
42,608
12.89
US$549,217
42,608 12.89 US$549,217
2026-07-02 2026-06-30 PlS Planned sale

Chief Legal Officer

Officer
6,566 -43.2%
14.00
US$91,924
6,566 -43.2% 14.00 US$91,924
2026-06-30 2026-06-30 PrS Proposed sale

Officer

Officer
6,566
12.88
US$84,570
6,566 12.88 US$84,570
2026-06-25 2026-06-23 S Sale

Chief Legal Officer

Officer
9,810 -53.2%
12.00
US$117,720
9,810 -53.2% 12.00 US$117,720
2026-06-23 2026-06-23 PrS Proposed sale

Officer

Officer
9,810
10.42
US$102,220
9,810 10.42 US$102,220
2026-06-23 2026-06-22 PlS Planned sale

See Remarks

Executive Director
114,746 -10.9%
10.47
US$1,200,851
114,746 -10.9% 10.47 US$1,200,851
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
114,746
10.42
US$1,195,653
114,746 10.42 US$1,195,653
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
114,746
10.42
US$1,195,653
114,746 10.42 US$1,195,653
2026-06-02 2026-06-01 PlS Planned sale

See Remarks

Executive Director
1,922 -0.2%
10.02
US$19,258
1,922 -0.2% 10.02 US$19,258
2026-06-01 2026-06-01 PrS Proposed sale

Officer

Officer
1,922
9.71
US$18,663
1,922 9.71 US$18,663
2026-03-24 2026-03-20 S Sale

VP, Finance and Controller

Officer
80 -0.2%
8.61
US$689
80 -0.2% 8.61 US$689
2026-03-24 2026-03-20 S Sale

VP, Finance and Controller

Officer
310 -0.7%
8.61
US$2,669
310 -0.7% 8.61 US$2,669
2025-12-23 2025-12-20 S Sale

VP, Finance and Controller

Officer
79 -0.2%
8.68
US$686
79 -0.2% 8.68 US$686
2025-12-23 2025-12-20 S Sale

VP, Finance and Controller

Officer
310 -0.7%
8.68
US$2,691
310 -0.7% 8.68 US$2,691
2025-12-19 2025-12-16 S Sale

Chief Legal Officer

Officer
1,635 -31.3%
10.90
US$17,822
1,635 -31.3% 10.90 US$17,822
2025-12-16 2025-12-16 PrS Proposed sale

Officer

Officer
1,635
10.95
US$17,903
1,635 10.95 US$17,903
2025-11-19 2025-11-17 PlS Planned sale

Chief Legal Officer

Officer
1,635 -31.3%
10.59
US$17,315
1,635 -31.3% 10.59 US$17,315
2025-11-17 2025-11-17 PrS Proposed sale

Officer

Officer
1,635
10.79
US$17,642
1,635 10.79 US$17,642
2025-10-27 2025-10-24 S Sale

Chief Legal Officer

Officer
2,678 -42.7%
12.00
US$32,136
2,678 -42.7% 12.00 US$32,136
2025-10-24 2025-10-24 PrS Proposed sale

Officer

Officer
1,816
10.00
US$18,160
1,816 10.00 US$18,160
2025-10-20 2025-10-16 PlS Planned sale

Chief Legal Officer

Officer
1,635 -24.0%
10.17
US$16,628
1,635 -24.0% 10.17 US$16,628
2025-10-14 2025-10-09 PlS Planned sale

Chief Legal Officer

Officer
2,408 -31.7%
10.00
US$24,080
2,408 -31.7% 10.00 US$24,080
2025-09-26 2025-09-23 PlS Planned sale

Chief Legal Officer

Officer
2,407 -24.1%
8.00
US$19,256
2,407 -24.1% 8.00 US$19,256
2025-09-23 2025-09-23 PrS Proposed sale

Officer

Officer
7,312
7.40
US$54,109
7,312 7.40 US$54,109
2024-09-18 2024-09-16 PlS Planned sale

Chief Legal Officer

Officer
500 -6.9%
16.33
US$8,165
500 -6.9% 16.33 US$8,165
2024-08-21 2024-08-19 PlS Planned sale

Chief Legal Officer

Officer
500 -6.9%
15.00
US$7,500
500 -6.9% 15.00 US$7,500
2024-07-18 2024-07-16 PlS Planned sale

Chief Legal Officer

Officer
1,750 -20.5%
27.11
US$47,442
1,750 -20.5% 27.11 US$47,442
2024-07-15 2024-07-11 PlS Planned sale

Chief Legal Officer

Officer
1,996 -22.7%
25.00
US$49,900
1,996 -22.7% 25.00 US$49,900
2024-07-12 2024-07-10 PlS Planned sale

Chief Executive Officer

Executive Director
12,923 -1.2%
22.49
US$290,598
12,923 -1.2% 22.49 US$290,598
2024-07-10 2024-07-10 PrS Proposed sale

Officer

Officer
12,923
23.21
US$299,943
12,923 23.21 US$299,943
2024-07-03 2024-07-01 PlS Planned sale

Chief Legal Officer

Officer
4,248 -71.0%
21.36
US$90,758
4,248 -71.0% 21.36 US$90,758
2024-07-01 2024-07-01 PrS Proposed sale

Officer

Officer
9,498
20.99
US$199,363
9,498 20.99 US$199,363
2024-06-26 2024-06-24 PlS Planned sale

Chief Executive Officer

Executive Director
12,930 -1.2%
23.10
US$298,711
12,930 -1.2% 23.10 US$298,711
2024-06-25 2024-06-24 PrS Proposed sale

Officer

Officer
12,930
23.25
US$300,622
12,930 23.25 US$300,622
2024-06-24 2024-06-24 PrS Proposed sale

Officer

Officer
12,930
23.25
US$300,622
12,930 23.25 US$300,622
2024-06-20 2024-06-17 PlS Planned sale

Chief Legal Officer

Officer
1,750 -50.2%
23.71
US$41,494
1,750 -50.2% 23.71 US$41,494
2024-05-20 2024-05-16 PlS Planned sale

Chief Legal Officer

Officer
467 -21.2%
25.75
US$12,027
467 -21.2% 25.75 US$12,027
2024-05-20 2024-05-16 PlS Planned sale

Chief Legal Officer

Officer
1,283 -36.8%
25.34
US$32,514
1,283 -36.8% 25.34 US$32,514
2024-04-18 2024-04-16 PlS Planned sale

Chief Legal Officer

Officer
1,750 -50.2%
25.74
US$45,045
1,750 -50.2% 25.74 US$45,045
2024-04-03 2024-04-01 PlS Planned sale

Chief Legal Officer

Officer
8,153 -82.4%
31.78
US$259,102
8,153 -82.4% 31.78 US$259,102
2024-04-01 2024-04-01 PrS Proposed sale

Officer

Officer
13,403
31.86
US$427,020
13,403 31.86 US$427,020
2024-03-29 2024-03-27 PlS Planned sale

Chief Legal Officer

Officer
5,833 -77.1%
35.04
US$204,410
5,833 -77.1% 35.04 US$204,410
2024-03-20 2024-03-18 PlS Planned sale

Chief Legal Officer

Officer
1,750 -50.2%
31.27
US$54,722
1,750 -50.2% 31.27 US$54,722
2024-02-29 2024-02-27 PlS Planned sale

Chief Legal Officer

Officer
1,909 -52.4%
30.00
US$57,270
1,909 -52.4% 30.00 US$57,270
2024-02-21 2024-02-16 PlS Planned sale

Chief Legal Officer

Officer
1,750 -50.2%
27.67
US$48,422
1,750 -50.2% 27.67 US$48,422
2024-02-12 2024-02-08 PlS Planned sale

Chief Legal Officer

Officer
1,996 -53.5%
27.50
US$54,890
1,996 -53.5% 27.50 US$54,890
2024-02-12 2024-02-08 PlS Planned sale

Chief Legal Officer

Officer
2,916 -62.7%
27.50
US$80,190
2,916 -62.7% 27.50 US$80,190
2024-02-12 2024-02-08 PlS Planned sale

Chief Legal Officer

Officer
1,332 -43.4%
27.50
US$36,630
1,332 -43.4% 27.50 US$36,630
2024-02-12 2024-02-08 PlS Planned sale

Chief Executive Officer

Executive Director
92,001 -8.0%
27.13
US$2,495,822
92,001 -8.0% 27.13 US$2,495,822
2024-02-08 2024-02-08 PrS Proposed sale

Officer

Officer
92,001
26.90
US$2,474,827
92,001 26.90 US$2,474,827
2024-02-08 2024-02-08 PrS Proposed sale

Officer

Officer
17,738
28.24
US$500,921
17,738 28.24 US$500,921
2024-02-07 2024-02-05 PlS Planned sale

Chief Medical Officer

Officer
552 -34.6%
30.05
US$16,588
552 -34.6% 30.05 US$16,588
2024-02-07 2024-02-05 PlS Planned sale

Chief Medical Officer

Officer
6,000 -79.0%
30.05
US$180,300
6,000 -79.0% 30.05 US$180,300
2024-02-07 2024-02-05 PlS Planned sale

Chief Medical Officer

Officer
6,000 -79.0%
30.05
US$180,300
6,000 -79.0% 30.05 US$180,300
2024-02-07 2024-02-05 PlS Planned sale

Chief Medical Officer

Officer
12,000 -88.3%
30.05
US$360,600
12,000 -88.3% 30.05 US$360,600
2024-01-25 2024-01-23 PlS Planned sale

Chief Executive Officer

Executive Director
5,696 -0.5%
18.41
US$104,851
5,696 -0.5% 18.41 US$104,851
2024-01-23 2024-01-23 PrS Proposed sale

Officer

Officer
5,696
18.46
US$105,148
5,696 18.46 US$105,148
2024-01-08 2024-01-05 PlS Planned sale

Chief Executive Officer

Executive Director
133 -0.0%
20.11
US$2,674
133 -0.0% 20.11 US$2,674
2024-01-08 2024-01-05 PlS Planned sale

Chief Executive Officer

Executive Director
28,104 -2.4%
19.56
US$549,804
28,104 -2.4% 19.56 US$549,804
2024-01-05 2024-01-05 PrS Proposed sale

Officer

Officer
28,237
19.59
US$553,163
28,237 19.59 US$553,163
2024-01-08 2024-01-04 PlS Planned sale

Chief Executive Officer

Executive Director
40,732 -3.3%
20.31
US$827,202
40,732 -3.3% 20.31 US$827,202
2024-01-05 2024-01-04 S Sale Large shareholder
540,000 -11.3%
19.53
US$10,546,200
540,000 -11.3% 19.53 US$10,546,200
2024-01-04 2024-01-04 PrS Proposed sale

Officer

Officer
40,732
20.05
US$816,677
40,732 20.05 US$816,677
2024-01-08 2023-12-18 PlS Planned sale

Chief Executive Officer

Executive Director
4,702 -0.4%
18.13
US$85,243
4,702 -0.4% 18.13 US$85,243
2023-12-18 2023-12-18 PrS Proposed sale

Officer

Officer
4,702
18.73
US$88,068
4,702 18.73 US$88,068
2024-01-08 2023-12-15 PlS Planned sale

Chief Executive Officer

Executive Director
28,632 -2.3%
17.27
US$494,432
28,632 -2.3% 17.27 US$494,432
2023-12-15 2023-12-15 PrS Proposed sale

Officer

Officer
28,632
17.76
US$508,504
28,632 17.76 US$508,504
2023-06-12 2023-06-08 PlS Planned sale

Chief Legal and HR Officer

Officer
3,750 -68.3%
20.85
US$78,188
3,750 -68.3% 20.85 US$78,188